---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-123088"
form_type: "8-K"
ticker: "RVP"
cik: "0000946563"
company_name: "RETRACTABLE TECHNOLOGIES INC"
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T19:07:28.395006+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# FDA Safety Communication on Chinese syringes does not affect Retractable Technologies

## Summary
- FDA Safety Communication dated Nov 30, 2023, warns of quality issues with plastic syringes made in China.
- Retractable Technologies confirms its syringes are not referenced in the FDA communication.
- VanishPoint safety syringe dimensions have not been recently changed, maintaining product integrity.
- Company reassures users that VanishPoint delivers correct dose and protects against needlesticks.

## SEC filing metadata
- accession: 0001104659-23-123088
- form_type: 8-K
- ticker: RVP
- cik: 0000946563
- company_name: RETRACTABLE TECHNOLOGIES INC
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946563/000110465923123088/0001104659-23-123088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946563/000110465923123088/tm2332097d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-123088
- JSON: https://secwatch.observer/filing/0001104659-23-123088.json
- Plain text: https://secwatch.observer/filing/0001104659-23-123088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.